These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12031545)

  • 21. Release of radiolabeled dopamine, serotonin, acetylcholine and GABA from slices of rat striatum after intrastriatal kainic acid injections.
    Frankhuyzen AL; Mulder AH
    Brain Res; 1977 Oct; 135(2):368-73. PubMed ID: 21721
    [No Abstract]   [Full Text] [Related]  

  • 22. Brain-derived neurotrophic factor inhibits spontaneous inhibitory postsynaptic currents in the rat supraoptic nucleus.
    Ohbuchi T; Yokoyama T; Saito T; Hashimoto H; Suzuki H; Otsubo H; Fujihara H; Suzuki H; Ueta Y
    Brain Res; 2009 Mar; 1258():34-42. PubMed ID: 19150437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Release of taurine, GABA and dopamine from rat striatal slices: mutual interactions and developmental aspects.
    Kontro P; Oja SS
    Neuroscience; 1988 Jan; 24(1):49-58. PubMed ID: 3368056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of amygdala-dependent learning by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol-3-kinase.
    Ou LC; Gean PW
    Neuropsychopharmacology; 2006 Feb; 31(2):287-96. PubMed ID: 16034442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endogenous brain-derived neurotrophic factor protects dopaminergic nigral neurons against transneuronal degeneration induced by striatal excitotoxic injury.
    Canudas AM; Pezzi S; Canals JM; Pallàs M; Alberch J
    Brain Res Mol Brain Res; 2005 Mar; 134(1):147-54. PubMed ID: 15790538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid stimulatory effects of brain-derived neurotrophic factor and neurotrophin-3 on somatostatin release and intracellular calcium rise in primary hypothalamic cell cultures.
    Marmigère F; Choby C; Rage F; Richard S; Tapia-Arancibia L
    Neuroendocrinology; 2001 Jul; 74(1):43-54. PubMed ID: 11435757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BDNF-TrkB signaling interacts with the GABAergic system to inhibit rhythmic swallowing in the rat.
    Bariohay B; Tardivel C; Pio J; Jean A; Félix B
    Am J Physiol Regul Integr Comp Physiol; 2008 Oct; 295(4):R1050-9. PubMed ID: 18685070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ability of 5-HT4 receptor ligands to modulate rat striatal dopamine release in vitro and in vivo.
    Steward LJ; Ge J; Stowe RL; Brown DC; Bruton RK; Stokes PR; Barnes NM
    Br J Pharmacol; 1996 Jan; 117(1):55-62. PubMed ID: 8825343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain-derived neurotrophic factor blocks long-term depression in solitary neurones cultured from rat visual cortex.
    Kumura E; Kimura F; Taniguchi N; Tsumoto T
    J Physiol; 2000 Apr; 524 Pt 1(Pt 1):195-204. PubMed ID: 10747192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The neurotrophins NT-4/5 and BDNF augment serotonin, dopamine, and GABAergic systems during behaviorally effective infusions to the substantia nigra.
    Altar CA; Boylan CB; Fritsche M; Jackson C; Hyman C; Lindsay RM
    Exp Neurol; 1994 Nov; 130(1):31-40. PubMed ID: 7821394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potentiated striatal dopamine release leads to hyperdopaminergia in female brain-derived neurotrophic factor heterozygous mice.
    Birbeck JA; Khalid M; Mathews TA
    ACS Chem Neurosci; 2014 Apr; 5(4):275-81. PubMed ID: 24517838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo.
    Altar CA; Boylan CB; Jackson C; Hershenson S; Miller J; Wiegand SJ; Lindsay RM; Hyman C
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11347-51. PubMed ID: 1454818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain-derived neurotrophic factor blocks long-term depression in rat visual cortex.
    Akaneya Y; Tsumoto T; Hatanaka H
    J Neurophysiol; 1996 Dec; 76(6):4198-201. PubMed ID: 8985915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain-derived neurotrophic factor-mediated retrograde signaling required for the induction of long-term potentiation at inhibitory synapses of visual cortical pyramidal neurons.
    Inagaki T; Begum T; Reza F; Horibe S; Inaba M; Yoshimura Y; Komatsu Y
    Neurosci Res; 2008 Jun; 61(2):192-200. PubMed ID: 18395922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo characterization of the angiotensin-(1-7)-induced dopamine and gamma-aminobutyric acid release in the striatum of the rat.
    Stragier B; Hristova I; Sarre S; Ebinger G; Michotte Y
    Eur J Neurosci; 2005 Aug; 22(3):658-64. PubMed ID: 16101747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Voluntary Exercise Boosts Striatal Dopamine Release: Evidence for the Necessary and Sufficient Role of BDNF.
    Bastioli G; Arnold JC; Mancini M; Mar AC; Gamallo-Lana B; Saadipour K; Chao MV; Rice ME
    J Neurosci; 2022 Jun; 42(23):4725-4736. PubMed ID: 35577554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain-derived neurotrophic factor regulation of N-methyl-D-aspartate receptor-mediated synaptic currents in suprachiasmatic nucleus neurons.
    Kim YI; Choi HJ; Colwell CS
    J Neurosci Res; 2006 Nov; 84(7):1512-20. PubMed ID: 16983663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BDNF enhances quantal neurotransmitter release and increases the number of docked vesicles at the active zones of hippocampal excitatory synapses.
    Tyler WJ; Pozzo-Miller LD
    J Neurosci; 2001 Jun; 21(12):4249-58. PubMed ID: 11404410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Excitatory actions of GABA increase BDNF expression via a MAPK-CREB-dependent mechanism--a positive feedback circuit in developing neurons.
    Obrietan K; Gao XB; Van Den Pol AN
    J Neurophysiol; 2002 Aug; 88(2):1005-15. PubMed ID: 12163549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ability of angiotensin II to modulate striatal dopamine release via the AT1 receptor in vitro and in vivo.
    Brown DC; Steward LJ; Ge J; Barnes NM
    Br J Pharmacol; 1996 May; 118(2):414-20. PubMed ID: 8735646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.